Dow Down0.02% Nasdaq Up0.07%

Alnylam Pharmaceuticals, Inc. (ALNY)

-NMS
97.21 Up 1.03(1.07%) Nov 25, 4:00PM EST
|After Hours : 97.19 Down 0.02 (0.02%) Nov 25, 4:31PM EST
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
Net Income (43,989) (44,074) (250,943) (32,357)
Operating Activities, Cash Flows Provided By or Used In
Depreciation3,117  2,868  2,600  2,627  
Adjustments To Net Income6,033  3,650  212,534  8,525  
Changes In Accounts Receivables(295)75  4,084  (3,639)
Changes In Liabilities(5,143)(7,283)(5,451)1,597  
Changes In Inventories -   -   -   -  
Changes In Other Operating Activities(429)(1,861)(4,499)878  
Total Cash Flow From Operating Activities (40,706) (46,625) (41,675) (22,369)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(3,195)(1,852)(388)(878)
Investments41,101  (226,523)(354,392)56,926  
Other Cash flows from Investing Activities -   -  (25,000) -  
Total Cash Flows From Investing Activities 37,906   (228,375) (379,780) 56,048  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock4,794  5,138  718,875  9,039  
Net Borrowings -   -   -   -  
Other Cash Flows from Financing Activities -   -   -  (1,389)
Total Cash Flows From Financing Activities 4,794   5,138   718,875   7,650  
Effect Of Exchange Rate Changes -   -   -   -  
Change In Cash and Cash Equivalents 1,994   (269,862) 297,420   41,329  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.